Sebastian Fähndrich

Has grant

University Medical Center Freiburg

Germany

Research Interests

Explore related searches

Professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Inhalable cathepsin inhibitor Aloxistatin on SARS-CoV-2 induced ARDS in ACE2 humanized mice

Open Date: 2024-03-01

Close Date: 2026-03-01

Grant: Close

CoViD-19-Aloxistatin – Präklinik und Phase-I Studie zur Sicherheit von inhalierbarem Aloxistatin (E64D) bei Patienten mit Covid-19

Open Date: 2020-06-01

Close Date: 2023-09-01

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (2)

Klaus Tenbrock

Medizinische Fakultät der RWTH Aachen

GERMANY

View details

Tobias Tenenbaum

Head

Sana Klinikum Lichtenberg

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sebastian Fähndrich

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

Success of the German Cystic Fibrosis Registry.

Vasoactive Intestinal Peptide (VIP) in COVID-19 Therapy—Shedding of ACE2 and TMPRSS2 via ADAM10

Association of Patients' Knowledge on the Disease and Its Management with Indicators of Disease Severity and Individual Characteristics in Patients with Chronic Obstructive Pulmonary Disease (COPD): Results from COSYCONET 2.

Skin Markers of Premature Ageing in Patients with COPD: Results Form COSYCONET.

A Multidimensional Approach to the Management of Patients in Prolonged Weaning from Mechanical Ventilation: The Concept of Treatable Traits - A Narrative Review.

Donor age over 55 is associated with worse outcome in lung transplant recipients with idiopathic pulmonary fibrosis.

Midregional Proatrial Natriuretic Peptide (MRproANP) is associated with vertebral fractures and low bone density in patients with chronic obstructive pulmonary disease (COPD).

Eosinopenia as Predictor of Disease Severity in Patients With Community-Acquired Pneumonia: An Observational Study.

[Alpha 1-antitrypsin deficiency].

Statins did not reduce the frequency of exacerbations in individuals with COPD and cardiovascular comorbidities in the COSYCONET cohort.

Collaborators (2)

Klaus Tenbrock

Tobias Tenenbaum

Make your next move.